Korean vaccine

Ansan-si, South Korea Founded: 1956 • Age: 70 yrs
Manufactures influenza vaccines and provides bio pharmaceutical testing globally.

About Korean vaccine

Korean vaccine is a Healthcare company based in Ansan-si (South Korea) founded in 1956. It manufactures influenza vaccines and provides bio pharmaceutical testing globally. It operates on a B2B and Contract Manufacturing model. Korean vaccine offers products and services including Coboxflu4gaPF Injection, Coboxinplu4gaPF Injection, Syringe, Needle, and Catheter. Its focus areas include Medical Devices, Equipment, Syringes and Needles and Biotechnology. Its legal entity in India is (μ£Ό)ν•œκ΅­λ°±μ‹  (U99999MH1977PLC010754).

Company details

Korea Vaccine is a South Korean company that produces influenza vaccines and other bio pharmaceuticals, offering contract manufacturing, storage, and analytical services. It operates facilities in Ansan and Seoul, serving global clients through WHO-standard GMP compliance and overseas expansions like in Indonesia. The company focuses on RD for medical products and ensures ethical, environmentally safe operations.

  • Headquarters Ansan-si, South Korea
  • Sectors
    Healthcare
  • Website koreavaccine.com
  • Legal Name (주)한국백신
  • Date of Incorporation 10 Aug, 1977
  • Jurisdiction Maharashtra, India

Products & Services of Korean vaccine

Korean vaccine offers a comprehensive portfolio of products and services, including Coboxflu4gaPF Injection, Coboxinplu4gaPF Injection, Syringe, Needle, and Catheter.

Coboxflu4gaPF Injection
Vaccine

Influenza vaccine for seasonal flu prevention and protection.

Coboxinplu4gaPF Injection
Vaccine

Divided influenza vaccine for immunization purposes.

Syringe
Medical Device

Device for vaccine administration and medical injections.

Needle
Medical Device

Component for safe delivery of vaccines and fluids.

Catheter
Medical Device

Tool for medical procedures and fluid management.

IV Set
Medical Device

System for intravenous delivery of medications.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Korean Vaccine

Premium access

Complete news archive for Korean vaccine

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Korean vaccine

Korean vaccine was founded in 1956.

Korean vaccine is headquartered in Ansan-si, South Korea. It is registered at Ansan-si, Gyeonggi-do, South Korea.

Korea Vaccine is a South Korean company that produces influenza vaccines and other bio pharmaceuticals, offering contract manufacturing, storage, and analytical services. It operates facilities in Ansan and Seoul, serving global clients through WHO-standard GMP compliance and overseas expansions like in Indonesia. The company focuses on RD for medical products and ensures ethical, environmentally safe operations.

Korean vaccine offers Coboxflu4gaPF Injection, Coboxinplu4gaPF Injection, Syringe, Needle, and 2 more products and services.

Korean vaccine operates through ,.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available